NO20006091L - Humant protein C-polypeptid - Google Patents
Humant protein C-polypeptidInfo
- Publication number
- NO20006091L NO20006091L NO20006091A NO20006091A NO20006091L NO 20006091 L NO20006091 L NO 20006091L NO 20006091 A NO20006091 A NO 20006091A NO 20006091 A NO20006091 A NO 20006091A NO 20006091 L NO20006091 L NO 20006091L
- Authority
- NO
- Norway
- Prior art keywords
- polypeptide
- human protein
- isolated
- disorders
- predispose
- Prior art date
Links
- 101500025568 Homo sapiens Saposin-D Proteins 0.000 title abstract 3
- 208000007536 Thrombosis Diseases 0.000 abstract 3
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 230000004071 biological effect Effects 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 229940100689 human protein c Drugs 0.000 abstract 1
- 201000005665 thrombophilia Diseases 0.000 abstract 1
- 230000002792 vascular Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6464—Protein C (3.4.21.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21069—Protein C activated (3.4.21.69)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Diabetes (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Cardiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Et isolert, humant protein C-polypeptid med avkortet tung kjede, er beskrevet. Dette isolerte polypeptid bibeholder den biologiske aktivitet av villtypehumant protein C. Dette polypeptid vil være nyttig ved behandling av vaskulære, okklusive lidelser, hyperkoagulerbare tilstander, trombotiske lidelser og sykdomstilstander som pre-disponerer for trombose.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8758598P | 1998-06-01 | 1998-06-01 | |
| PCT/US1999/011969 WO1999063070A1 (en) | 1998-06-01 | 1999-06-01 | Human protein c polypeptide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20006091D0 NO20006091D0 (no) | 2000-11-30 |
| NO20006091L true NO20006091L (no) | 2001-01-31 |
Family
ID=22206075
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20006091A NO20006091L (no) | 1998-06-01 | 2000-11-30 | Humant protein C-polypeptid |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US20040038288A1 (no) |
| EP (1) | EP1084235A4 (no) |
| JP (1) | JP2002517191A (no) |
| KR (1) | KR20010043941A (no) |
| CN (1) | CN1303428A (no) |
| AR (1) | AR020082A1 (no) |
| AU (1) | AU4409399A (no) |
| BR (1) | BR9910858A (no) |
| CA (1) | CA2330171A1 (no) |
| CO (1) | CO5070672A1 (no) |
| DZ (1) | DZ2803A1 (no) |
| EA (1) | EA200001254A1 (no) |
| HR (1) | HRP20000826A2 (no) |
| HU (1) | HUP0102014A3 (no) |
| ID (1) | ID27282A (no) |
| IL (1) | IL139595A0 (no) |
| NO (1) | NO20006091L (no) |
| NZ (1) | NZ507982A (no) |
| PE (1) | PE20000561A1 (no) |
| PL (1) | PL344349A1 (no) |
| SK (1) | SK17502000A3 (no) |
| SV (1) | SV1999000067A (no) |
| TR (1) | TR200003552T2 (no) |
| WO (1) | WO1999063070A1 (no) |
| ZA (1) | ZA200006647B (no) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8821884B2 (en) * | 2004-07-27 | 2014-09-02 | The Regents Of The University Of California | Compositions and methods using MD-2 mutants and chimeric proteins |
| CN108159399B (zh) * | 2017-12-29 | 2020-07-24 | 华中科技大学同济医学院附属同济医院 | 一种凝血蛋白酶aPC在防治糖尿病心肌病药物中的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2728240B2 (ja) * | 1988-07-26 | 1998-03-18 | ヘキスト薬品工業株式会社 | ヒトプロテインc変異体及びその製造方法 |
| AU7168591A (en) * | 1989-12-29 | 1991-07-24 | Zymogenetics Inc. | Hybrid protein c |
| JPH05506354A (ja) * | 1990-02-09 | 1993-09-22 | ザイモジェネティクス,インコーポレイティド | 端が切り取られた軽鎖を有する活性プロテインc |
| JPH0564588A (ja) * | 1991-08-14 | 1993-03-19 | Teijin Ltd | 短い重鎖を有するヒトプロテインcおよび活性化ヒトプロテインc |
-
1999
- 1999-05-28 SV SV1999000067A patent/SV1999000067A/es not_active Application Discontinuation
- 1999-05-31 AR ARP990102575A patent/AR020082A1/es not_active Application Discontinuation
- 1999-06-01 CO CO99034013A patent/CO5070672A1/es unknown
- 1999-06-01 IL IL13959599A patent/IL139595A0/xx unknown
- 1999-06-01 PE PE1999000461A patent/PE20000561A1/es not_active Application Discontinuation
- 1999-06-01 EP EP99927111A patent/EP1084235A4/en not_active Withdrawn
- 1999-06-01 HR HR20000826A patent/HRP20000826A2/hr not_active Application Discontinuation
- 1999-06-01 EA EA200001254A patent/EA200001254A1/ru unknown
- 1999-06-01 WO PCT/US1999/011969 patent/WO1999063070A1/en not_active Ceased
- 1999-06-01 BR BR9910858-5A patent/BR9910858A/pt not_active IP Right Cessation
- 1999-06-01 JP JP2000552266A patent/JP2002517191A/ja not_active Withdrawn
- 1999-06-01 KR KR1020007013511A patent/KR20010043941A/ko not_active Withdrawn
- 1999-06-01 CA CA002330171A patent/CA2330171A1/en not_active Abandoned
- 1999-06-01 ID IDW20002430A patent/ID27282A/id unknown
- 1999-06-01 SK SK1750-2000A patent/SK17502000A3/sk unknown
- 1999-06-01 DZ DZ990103A patent/DZ2803A1/xx active
- 1999-06-01 NZ NZ507982A patent/NZ507982A/en not_active Application Discontinuation
- 1999-06-01 CN CN99806859A patent/CN1303428A/zh active Pending
- 1999-06-01 HU HU0102014A patent/HUP0102014A3/hu unknown
- 1999-06-01 AU AU44093/99A patent/AU4409399A/en not_active Abandoned
- 1999-06-01 PL PL99344349A patent/PL344349A1/xx not_active Application Discontinuation
- 1999-06-01 TR TR2000/03552T patent/TR200003552T2/xx unknown
-
2000
- 2000-11-15 ZA ZA200006647A patent/ZA200006647B/en unknown
- 2000-11-30 NO NO20006091A patent/NO20006091L/no not_active Application Discontinuation
-
2003
- 2003-09-25 US US10/670,628 patent/US20040038288A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20040038288A1 (en) | 2004-02-26 |
| IL139595A0 (en) | 2002-02-10 |
| WO1999063070A1 (en) | 1999-12-09 |
| HUP0102014A2 (hu) | 2001-10-28 |
| EA200001254A1 (ru) | 2001-06-25 |
| AU4409399A (en) | 1999-12-20 |
| SV1999000067A (es) | 2000-07-06 |
| NO20006091D0 (no) | 2000-11-30 |
| BR9910858A (pt) | 2001-03-06 |
| AR020082A1 (es) | 2002-04-10 |
| PL344349A1 (en) | 2001-11-05 |
| HRP20000826A2 (en) | 2001-10-31 |
| CA2330171A1 (en) | 1999-12-09 |
| NZ507982A (en) | 2004-01-30 |
| ZA200006647B (en) | 2001-11-15 |
| PE20000561A1 (es) | 2000-07-22 |
| TR200003552T2 (tr) | 2001-05-21 |
| ID27282A (id) | 2001-03-22 |
| EP1084235A1 (en) | 2001-03-21 |
| CO5070672A1 (es) | 2001-08-28 |
| HUP0102014A3 (en) | 2003-09-29 |
| JP2002517191A (ja) | 2002-06-18 |
| EP1084235A4 (en) | 2002-03-27 |
| CN1303428A (zh) | 2001-07-11 |
| DZ2803A1 (fr) | 2003-12-01 |
| KR20010043941A (ko) | 2001-05-25 |
| SK17502000A3 (sk) | 2001-09-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0733109T3 (da) | BMP-12, BMP-13 og seneinducerende præparater dermed | |
| TR199801390T2 (xx) | Tromboz tedavisinde kullan�lacak p�ht�la�may� �nleyici maddeler | |
| DE60042137D1 (de) | Rekombinante alpha-l-iduronidase und behandlung von durch diese hervorgerufene mangelerkrankungen | |
| DE60233955D1 (de) | Spezifische bindungsmittel von human angiopoietin-2 | |
| DE60045034D1 (de) | Überstände von mesenchymstammzellen zur vorbeugung und behandlung von immunantworten in transplantationen | |
| SE8902532D0 (sv) | Bestaemning av plasmaproteiner | |
| DE69921156D1 (de) | Verwendung von 5ht-6 antagonisten zur behandlung adhd | |
| DE3579113D1 (de) | Zusammensetzungen zur milderung, behandlung und bestimmungung von arthritschen krankheiten und aehnlichen zustaenden. | |
| DE60229406D1 (de) | Verfahren zur behandlung oder verhinderung von vaskulärer entzündung mit sterol-absorbierungs- inhibitor(en) | |
| DE69932845D1 (de) | Methoden zur quantifizierung von hla-dr und cd11b | |
| ATE275411T1 (de) | Verwendung von phyllanthus zur behandlung von chronisch entzündlichen und fibrotischen prozessen | |
| PT948604E (pt) | Produtos e metodos relacionados com pyk2 | |
| DE69838509D1 (de) | Verwendung von rekombinanten menschlichen uteroglobin zur behandlung von fibrotischen krankheitszuständen | |
| DE69033511D1 (de) | Verfahren zum Nachweis von Knochen- und anderen Bindegewebeerkrankungen in Menschen und Tieren | |
| ES2113878T3 (es) | Proteina c hibrida. | |
| BR9007115A (pt) | Novo trombolitico | |
| ATE313561T1 (de) | Vgf polypeptide und verfahren zur behandlung von vgf-erkrankungen | |
| ATE286122T1 (de) | Protein c derivate | |
| DE69932922D1 (de) | Verwendung von alkansäuren-enthaltenden zusammensetzungen zur behandlung von nagelpilz-erkrankungen | |
| WO1999058098A3 (en) | HUMAN ANTITHROMBIN IIIs AND METHODS RELATED THERETO | |
| EA200401390A1 (ru) | N-ацетилглюкозамин-6-фосфатдеацетилаза человека, взаимодействующая с каспазой-8, и способы ее применения | |
| DE60118769D1 (de) | Verwendung von langem pentraxin ptx3 zur behanlung von durch geänderte aktivität des fgf-2 wachstumsfaktors hervorgerufene krankheiten | |
| ATE312914T1 (de) | Rdgb-proteine | |
| ATE117549T1 (de) | Lysyl-oxidase-inhibitoren. | |
| DE59813914D1 (de) | Mittel zur behandlung und/oder prophylaxe von mikrozirkulationsstörungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |